TXG logo

10x Genomics, Inc. (TXG) Cash From Investing

Annual CFI:

-$32.63M-$166.12M(-124.44%)
December 31, 2024

Summary

  • As of today, TXG annual cash from investing is -$32.63 million, with the most recent change of -$166.12 million (-124.44%) on December 31, 2024.
  • During the last 3 years, TXG annual cash from investing has risen by +$74.10 million (+69.43%).
  • TXG annual cash from investing is now -124.44% below its all-time high of $133.49 million, reached on December 31, 2023.

Performance

1-Year Change

-124.44%

3-Year Change

+69.43%

5-Year Change

+23.7%

15-Year Change

-768.77%

TXG Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

26.47%
TXG annual cash from investing is higher than 26.47% of companies in Healthcare sector

Range

All-Time High

$133.49M
TXG annual cash from investing is currently -124.44% below its historical high of $133.49 million

3-Year Low

-$350.89M
TXG annual cash from investing is currently +90.70% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TXG previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 11, 2026
TXG next annual earnings announcement is scheduled for Feb 11, 2026

OtherTXGcash flow metrics

Annual CFF

$10.91M
TXG annual cash from financing is $10.91 million

Annual CFO

$6.66M
TXG annual cash from operations is $6.66 million

Annual FCF

-$6.73M
TXG annual free cash flow is -$6.73 million

Annual CAPEX

$13.39M
TXG annual capital expenditures is $13.39 million

Quarterly CFI:

-$8.80M-$7.86M(-837.27%)
September 30, 2025

Summary

  • As of today, TXG quarterly cash from investing is -$8.80 million, with the most recent change of -$7.86 million (-837.27%) on September 30, 2025.
  • Over the past year, TXG quarterly cash from investing has dropped by -$5.18 million (-143.26%).
  • TXG quarterly cash from investing is now -107.34% below its all-time high of $119.96 million, reached on March 31, 2023.

Performance

3-Month Change

-837.27%

1-Year Change

-143.26%

3-Year Change

+73.03%

5-Year Change

-571.83%

TXG Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

22.81%
TXG quarterly cash from investing is higher than 22.81% of companies in Healthcare sector

Range

All-Time High

$119.96M
TXG quarterly cash from investing is currently -107.34% below its historical high of $119.96 million

3-Year Low

-$51.59M
TXG quarterly cash from investing is currently +82.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
TXG previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 11, 2026
TXG next earnings announcement is scheduled for Feb 11, 2026

OtherTXGcash flow metrics

Quarterly CFF

$617.00K
TXG quarterly cash from financing is $617.00 thousand

Quarterly CFO

$43.21M
TXG quarterly cash from operations is $43.21 million

Quarterly FCF

$33.91M
TXG quarterly free cash flow is $33.91 million

Quarterly CAPEX

$9.30M
TXG quarterly capital expenditures is $9.30 million

TTM CFI:

-$63.23M-$5.18M(-8.93%)
September 30, 2025

Summary

  • As of today, TXG TTM cash from investing is -$63.23 million, with the most recent change of -$5.18 million (-8.93%) on September 30, 2025.
  • Over the past year, TXG TTM cash from investing has dropped by -$95.28 million (-297.21%).
  • TXG TTM cash from investing is now -147.36% below its all-time high of $133.49 million, reached on December 31, 2023.

Performance

3-Month Change

-8.93%

1-Year Change

-297.21%

3-Year Change

+81.69%

5-Year Change

-178.41%

TXG TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

20.09%
TXG TTM cash from investing is higher than 20.09% of companies in Healthcare sector

Range

All-Time High

$133.49M
TXG TTM cash from investing is currently -147.36% below its historical high of $133.49 million

3-Year Low

-$350.89M
TXG TTM cash from investing is currently +81.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
TXG previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 11, 2026
TXG next earnings announcement is scheduled for Feb 11, 2026

OtherTXGcash flow metrics

TTM CFF

$9.08M
TXG TTM cash from financing is $9.08 million

TTM CFO

$88.53M
TXG TTM cash from operations is $88.53 million

TTM FCF

$73.03M
TXG TTM free cash flow is $73.03 million

TTM CAPEX

$15.49M
TXG TTM capital expenditures is $15.49 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TXG Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-124.4%-143.3%-297.2%
3Y3 Years+69.4%+73.0%+81.7%
5Y5 Years+23.7%-571.8%-178.4%

TXG Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-124.4%+90.7%-107.3%+82.9%-147.4%+82.0%
5Y5-Year-124.4%+90.7%-107.3%+96.6%-147.4%+82.0%
All-TimeAll-Time-124.4%+90.7%-107.3%+96.6%-147.4%+82.0%

TXG Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$8.80M(-837.3%)
-$63.23M(-8.9%)
Jun 2025
-
-$939.00K(+50.4%)
-$58.04M(-28.5%)
Mar 2025
-
-$1.89M(+96.3%)
-$45.16M(-38.4%)
Dec 2024
-$32.63M(-124.4%)
-$51.59M(-1326.0%)
-$32.63M(-201.8%)
Sep 2024
-
-$3.62M(-130.3%)
$32.06M(-21.0%)
Jun 2024
-
$11.95M(+12.4%)
$40.58M(+67.9%)
Mar 2024
-
$10.63M(-18.8%)
$24.17M(-81.9%)
Dec 2023
$133.49M(+138.0%)
$13.10M(+167.3%)
$133.49M(+53.0%)
Sep 2023
-
$4.90M(+209.8%)
$87.22M(+75.5%)
Jun 2023
-
-$4.46M(-103.7%)
$49.69M(+86.6%)
Mar 2023
-
$119.96M(+461.6%)
$26.63M(+107.6%)
Dec 2022
-$350.89M
-$33.17M(-1.7%)
-$350.89M(-1.6%)
Sep 2022
-
-$32.63M(-18.5%)
-$345.33M(-3.7%)
Jun 2022
-
-$27.53M(+89.3%)
-$332.93M(-4.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$257.56M(-832.6%)
-$319.97M(-199.8%)
Dec 2021
-$106.73M(-178.0%)
-$27.62M(-36.5%)
-$106.73M(-5.3%)
Sep 2021
-
-$20.23M(-38.8%)
-$101.38M(-22.9%)
Jun 2021
-
-$14.57M(+67.1%)
-$82.46M(-10.5%)
Mar 2021
-
-$44.32M(-99.0%)
-$74.63M(-94.4%)
Dec 2020
-$38.39M(+10.2%)
-$22.27M(-1599.7%)
-$38.39M(-69.1%)
Sep 2020
-
-$1.31M(+80.6%)
-$22.71M(+35.3%)
Jun 2020
-
-$6.74M(+16.6%)
-$35.08M(+15.4%)
Mar 2020
-
-$8.08M(-22.8%)
-$41.48M(+3.0%)
Dec 2019
-$42.77M(-537.5%)
-$6.58M(+51.9%)
-$42.77M(-18.2%)
Sep 2019
-
-$13.68M(-4.1%)
-$36.19M(-60.8%)
Jun 2019
-
-$13.14M(-40.3%)
-$22.51M(-140.3%)
Mar 2019
-
-$9.37M
-$9.37M
Dec 2018
-$6.71M(-78.6%)
-
-
Dec 2017
-$3.76M
-
-

FAQ

  • What is 10x Genomics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual cash from investing year-on-year change?
  • What is 10x Genomics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly cash from investing year-on-year change?
  • What is 10x Genomics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM cash from investing year-on-year change?

What is 10x Genomics, Inc. annual cash from investing?

The current annual cash from investing of TXG is -$32.63M

What is the all-time high annual cash from investing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual cash from investing is $133.49M

What is 10x Genomics, Inc. annual cash from investing year-on-year change?

Over the past year, TXG annual cash from investing has changed by -$166.12M (-124.44%)

What is 10x Genomics, Inc. quarterly cash from investing?

The current quarterly cash from investing of TXG is -$8.80M

What is the all-time high quarterly cash from investing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly cash from investing is $119.96M

What is 10x Genomics, Inc. quarterly cash from investing year-on-year change?

Over the past year, TXG quarterly cash from investing has changed by -$5.18M (-143.26%)

What is 10x Genomics, Inc. TTM cash from investing?

The current TTM cash from investing of TXG is -$63.23M

What is the all-time high TTM cash from investing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM cash from investing is $133.49M

What is 10x Genomics, Inc. TTM cash from investing year-on-year change?

Over the past year, TXG TTM cash from investing has changed by -$95.28M (-297.21%)
On this page